440 Mg Trastuzumab Lyophilized Powder

Name: 440 Mg Trastuzumab Lyophilized Powder
Brand: NEETCO BIOPHARMA
Price: 20000 INR
Availability: InStock

Price 20000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

440 Mg Trastuzumab Lyophilized Powder Specification

Salt Composition
Trastuzumab 440 mg

Indication
HER2-positive breast cancer, HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma

Dosage Form
Lyophilized Powder for Injection

Enzyme Types
Monoclonal antibody (not an enzyme)

Feature
High purity, specifically targets HER2 receptor, for targeted cancer therapy

Ingredients
Active: Trastuzumab; Excipients: L-histidine, L-histidine hydrochloride, trehalose dihydrate, polysorbate 20

Application
For intravenous administration after reconstitution

Ph Level
Approximately 6.0

Temperature Needed For Fermentation
Not applicable (biotechnological production)

Physical Color/Texture
White to pale yellow lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable (monoclonal antibody)

Storage Instructions
Store at 2C to 8C (36F to 46F), do not freeze

Shelf Life
36 months from date of manufacture if unopened and stored properly

Prescription Status
Prescription only medication

Contraindications
Known hypersensitivity to Trastuzumab or any excipients

Container Material
Clear glass vial

Pack Size
440 mg vial with appropriate diluent for reconstitution

Administration Route
Intravenous infusion only

Manufacturing Information
Produced using Chinese Hamster Ovary (CHO) cells

Reconstitution Volume
20 mL of sterile water for injection

Patient Population
Adults

Precautions
Monitor for infusion reactions and cardiac toxicity

USP Compliance
Conforms to internationally accepted pharmacopeial standards

Packaging Type
Single-use vial with sterile water for injection diluent

About 440 Mg Trastuzumab Lyophilized Powder

Unlock transcendent precision in cancer care with our Prime 440 mg Trastuzumab Lyophilized Powder-clearance pricing and advance purchase options now available for leading hospitals and providers. Specially designed for adult intravenous infusions, this top-rated product arrives in a single-use glass vial, with 20 mL of sterile water for seamless reconstitution. Trastuzumab, a monoclonal antibody of formidable purity, is indicated for HER2-positive breast cancer and metastatic gastric or gastroesophageal adenocarcinoma. USP-compliant and meticulously produced using CHO cells, each triumphant dose delivers targeted, reliable therapy. Strictly prescription-only.

Distinctive Features and Applications of 440 Mg Trastuzumab Lyophilized Powder

Boasting high purity and manufactured via biotechnological processes, 440 mg Trastuzumab Lyophilized Powder is a top-rated option for targeted therapy in HER2-positive cancers. It is administered intravenously after careful reconstitution, ensuring effective delivery to adult patients. Suitable for both initial and ongoing treatment regimens, this product offers a prime solution for oncologists seeking precision and consistency. With each application, it delivers powerful, localized action against cancer cells, exemplifying transcendent progress in oncology care.

Export Markets, Shipment Handling, and Packaging Details

Renowned for swift shipment and steady supply, our triumphant Trastuzumab formulation is widely exported to international markets through prime Indian FOB ports. We ensure quick dispatch and seamless exchange processes for global distributors, exporters, suppliers, and traders. Each vial is carefully packaged with its sterile diluent to maintain integrity and guarantee patient safety. Our robust packaging and proactive shipment strategies bolster customer satisfaction and instill confidence in product reliability.

FAQ's of 440 Mg Trastuzumab Lyophilized Powder:

Q: How is 440 mg Trastuzumab Lyophilized Powder administered?

A: The powder is reconstituted with 20 mL of sterile water for injection and administered exclusively via intravenous infusion under medical supervision.

Q: What are the primary indications for using 440 mg Trastuzumab?

A: This medication is indicated for adults with HER2-positive breast cancer and metastatic gastric or gastroesophageal junction adenocarcinoma, providing targeted monoclonal antibody therapy.

Q: When should infusion reactions or cardiac toxicity be monitored?

A: Patients should be closely monitored during and after each infusion, especially during the initial doses, as infusion reactions and potential cardiac toxicity may occur.

Q: Where should the product be stored to maintain efficacy?

A: Store the vial at 2C to 8C (36F to 46F) in a refrigerator. Do not freeze, and ensure it remains in its original packaging until use to preserve quality.

Q: What is the process for reconstituting 440 mg Trastuzumab for intravenous use?

A: Using the enclosed sterile water for injection, slowly add 20 mL to the vial, gently swirl (not shake), and ensure complete dissolution before intravenous administration.

Q: What are the benefits of advance purchase or clearance deals for distributors?

A: Advance purchase and clearance offers allow distributors to secure top-rated Trastuzumab at competitive prices, ensuring uninterrupted supply and optimal inventory management.

Tell us about your requirement